Fluzac

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fluzac

Quick Facts About Fluzac

Property Description
Active Ingredient Fluoxetine Hydrochloride
Form Capsule, Tablet, Oral Solution
Pharmacological Class Selective Serotonin Reuptake Inhibitor (SSRI)
Common Use Mood Regulation and Affective Disorders
Origin Synthetic Compound

What Type of Medicine Is Fluzac (Fluoxetine)?

Fluzac is a prescription-only psychotropic agent primarily classified as an antidepressant, with its action rooted in the regulation of specific chemical messengers in the central nervous system. The drug belongs to the widely recognized pharmacological class of Selective Serotonin Reuptake Inhibitors (SSRIs). As an SSRI, the drug operates by increasing the availability of serotonin in the brain. This classification signifies that the core function of the active substance, Fluoxetine, is to selectively influence the activity of this key neurotransmitter essential for mood regulation. Fluoxetine is clinically recognized for its pharmacological profile, which provides a foundation for addressing underlying imbalances related to affective disorders.


Fluzac Composition and Available Forms

The therapeutic effect of Fluzac is delivered by its single active ingredient, Fluoxetine Hydrochloride, which is a stable, synthetic compound. This single-component preparation, although known commercially under various trade names, is fundamentally defined by the Fluoxetine molecule. Use of the substance is established across multiple presentations, including capsules and tablets. The various dosage forms—the oral solid preparations and the oral liquid preparation (solution)—ensure flexibility for the oral route of administration while consistently delivering the active substance.

Regulatory References

  1. U.S. National Library of Medicine (NIH)

What side effects are possible with Fluzac?

Possible Side Effects and Safety Information

The safety profile of Fluzac (Fluoxetine) is documented through regulatory classification of adverse reactions based on frequency and affected body systems. Official regulatory categories for incidence include Very Common (ge 1/10), Common (ge 1/100 to < 1/10), and less frequent classifications. Very Common adverse reactions reported in clinical trials include insomnia and headache.

Commonly reported reactions involve several System-Organ Classes (SOCs), such as Gastrointestinal Disorders (e.g., nausea, diarrhea, dry mouth), Nervous System Disorders (e.g., tremor, dizziness), Psychiatric Disorders (e.g., anxiety, nervousness), and Reproductive System Disorders (e.g., sexual dysfunction).

Documented Serious Safety Risks

Regulatory authorities highlight several serious adverse reactions. A Boxed Warning addresses the increased risk of Suicidal Thoughts and Behavior in children, adolescents, and young adults, particularly during treatment initiation or dose changes. Other documented serious risks include Serotonin Syndrome or Neuroleptic Malignant Syndrome (NMS)-like Reactions, QT Prolongation with associated Ventricular Arrhythmias, and an increased risk of Abnormal Bleeding.

Population-Specific Considerations

The label includes specific safety notes for certain populations. For patients with Hepatic Impairment, a lower or less frequent dosing schedule should be considered due to the prolonged half-life of the drug and its active metabolite. Warnings also address use in pregnancy, noting the risk of Persistent Pulmonary Hypertension of the Newborn (PPHN) with late-term exposure.

Safety Restrictions

Fluzac is officially Contraindicated for concurrent use with Monoamine Oxidase Inhibitors (MAOIs) due to the risk of serious reactions, and with medications like Pimozide and Thioridazine due to risks of cardiac safety issues.

Overdose and Emergency Response

Overdose and when to seek help

This information describes the documented manifestations of Fluzac (Fluoxetine) overdose and the immediate actions mandated by regulatory authorities, based on documented human experience in prescribing information (e.g., FDA/EMA). Overdose may lead to severe and potentially life-threatening outcomes.


Documented Overdose Presentations

System Documented Manifestations (Signs and Symptoms)
Cardiovascular Tachycardia, QT Prolongation, Ventricular Arrhythmia
CNS Seizures, Coma, Drowsiness, Tremor, Agitation
Gastrointestinal Nausea, Vomiting, Diarrhea

Life-Threatening Outcomes and Emergency Actions

Overdose carries a documented risk for the development of Serotonin Syndrome or serious cardiac events such as Torsades de Pointes. No specific antidote is known for Fluoxetine overdose, and treatment focuses entirely on symptomatic and supportive measures, including ensuring adequate airway management and continuous ECG monitoring due to cardiac risk.

Immediate medical attention is required. Regulatory guidance explicitly states that emergency services must be contacted immediately (e.g., 911) if the person has collapsed, had a seizure, has trouble breathing, or can't be awakened.

Therapeutic Uses of Fluzac

What Fluzac Treats: Main Uses and Benefits

Fluzac (Fluoxetine) is commonly used across several key domains of mental health, applied where additional symptomatic support is needed. It is generally applied when distressing symptoms lead to noticeable interference with a patient's daily life and overall comfort.

It helps address symptom clusters that may become intense or disruptive across conditions such as Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), Panic Disorder, Bulimia Nervosa, and Premenstrual Dysphoric Disorder (PMDD). The medication is relevant in clinical settings that involve acute or unstable symptom patterns and is used for managing manifestations like persistent low mood, intrusive thoughts, and dysfunctional behaviors.

“It helps maintain a sense of stability when symptoms are more noticeable, assisting with functional comfort during symptomatic periods.”

This supportive relief contributes to improved comfort during periods of heightened symptoms and assists with maintaining functional stability.

Quick Fact: Relief for Key Symptom Domains
Mood Helps manage symptoms of severe low mood and loss of interest.
Anxiety Provides support that helps ease the intensity and frequency of panic attacks.
Behavioral Applied in addressing episodes of binge-eating and purging in Bulimia Nervosa.

Eligibility and Restrictions for Use

Who Can and Cannot Use Fluzac?

Fluzac (Fluoxetine) is a prescription medication primarily used to treat major depressive disorder, obsessive-compulsive disorder (OCD), bulimia nervosa, and panic disorder. Its use is determined by a healthcare provider after a thorough medical assessment.

Who Can Typically Use Fluzac?

Generally, adults and children/adolescents (for specific conditions and under close monitoring) can use Fluzac if the benefits outweigh the potential risks and if they do not have any contraindications listed below. Dosage is highly individualized.


Who Should Avoid or Exercise Caution with Fluzac?

Certain conditions and drug interactions make Fluzac unsuitable or require close medical supervision. The most significant contraindications include:

Condition/Interaction Reason for Caution/Avoidance
Monoamine Oxidase Inhibitors (MAOIs) Risk of Serotonin Syndrome, a potentially life-threatening reaction. Fluzac should not be started within 14 days of stopping an MAOI.
Thioridazine or Pimozide Increased risk of serious heart rhythm problems (QT prolongation).
Known hypersensitivity Allergic reaction to fluoxetine or any inactive ingredients.
Severe renal/hepatic impairment May require dosage adjustment due to altered drug clearance.

Patients with bipolar disorder, a history of seizures, or narrow-angle glaucoma must also be monitored carefully.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation requires strict restrictions regarding the co-administration of Fluzac with certain other medicines.

Contraindicated Combinations

  • Monoamine Oxidase Inhibitors (MAOIs): Co-administration is explicitly prohibited due to a high risk of serious, sometimes fatal, Serotonin Syndrome. A minimum 14-day washout period is required after stopping an MAOI before starting Fluzac, and at least a five-week washout period is required after stopping Fluzac before starting an MAOI.
  • Pimozide and Thioridazine: These medicines are contraindicated with Fluzac due to the risk of QTc interval prolongation and elevated concentrations of the co-administered medicine.

Clinically Significant Interactions

  • Serotonergic Agents: Caution is necessary when combining Fluzac with other serotonergic medicines (such as Triptans, Tricyclic Antidepressants, Fentanyl, Lithium, Tramadol, and St. John's Wort) because of the elevated risk of Serotonin Syndrome.
  • Drugs Metabolized by CYP2D6: Fluzac is a potent inhibitor of the CYP2D6 enzyme, which can increase the blood concentration of co-administered medicines that are metabolized by this pathway, including certain antipsychotics, antiarrhythmics (like Propafenone and Flecainide), and Tricyclic Antidepressants.
  • Anticoagulants and Antiplatelet Drugs: Co-administration with Warfarin, NSAIDs, or Aspirin may increase the risk of abnormal bleeding, requiring close monitoring of coagulation status.

Mechanism of Action

How Fluzac Works

Fluzac (fluoxetine) exerts its mechanism of action primarily through the selective inhibition of the Serotonin Reuptake Transporter (SERT) protein in the Central Nervous System (CNS). By blocking SERT, the drug prevents the reabsorption of serotonin into the presynaptic neuron, resulting in a sustained elevation of extracellular serotonin concentration in the synaptic cleft.

This increased signaling initiates a crucial, time-dependent neuroadaptive cascade. Over several weeks, the elevated serotonin levels cause the downregulation and desensitization of inhibitory presynaptic 5-HT₁A autoreceptors, which allows for robust, persistent serotonergic neurotransmission. Concurrently, this chronic signaling promotes the upregulation of Brain-Derived Neurotrophic Factor (BDNF), which governs neuronal plasticity and long-term alteration of signaling pathway activity.

Fluzac's profile is further defined by the activity of its active metabolite, norfluoxetine, which maintains continuous SERT inhibition. Additionally, fluoxetine acts as an antagonist at the 5-HT₂C receptor, indirectly modulating the release of dopamine and norepinephrine, contributing to a broader modulation of neurochemical balance.

Dosage and Administration Information

The administration of Fluzac (Fluoxetine) is standardized across its available forms and therapeutic protocols. The medicine is indicated for the oral route of administration and is available as capsules, tablets, or an oral solution, including a 90 mg delayed-release capsule intended for once-weekly use. For most adult indications, the standard starting dose is 20 mg taken once daily, typically in the morning.

Depending on the specific condition, the daily dose may be adjusted in increments after a period of several weeks, generally ranging between 20 mg and a maximum of 80 mg per day. The fixed dose for Bulimia Nervosa, however, is standardized at 60 mg once daily. Fluoxetine can be taken with or without food, as its absorption is not clinically affected by meal timing. Higher doses (exceeding 20 mg) may be administered on a twice-daily schedule (morning and noon) to aid in adherence.

Clinical protocols specify modifications for certain groups; for example, a lower or less frequent dosage is recommended for older adults and patients with hepatic impairment. A specific procedural constraint involves transitioning to other drug classes: a mandatory five-week washout period must be observed after stopping Fluoxetine before starting a Monoamine Oxidase Inhibitor (MAOI). When using the liquid formulation, it must be shaken well and measured with a precise device to ensure accurate intake.

Recent Clinical Evidence

Research evidence / Overview of studies for Fluzac

Evidence for Management of Mood and Anxiety Disorders

The research on Fluzac is primarily based on short-term, placebo-controlled, randomized clinical trials (RCTs). These studies examine how symptoms change over defined time intervals. For Major Depressive Disorder (MDD), trials, typically lasting 8 to 12 weeks, monitor outcomes using standardized scales. Studies reported measurements where changes in symptom severity scale scores were observed to be numerically different than those reported by the inactive control (placebo).

Maintenance trials also monitor patterns over longer periods, sometimes up to a year, including measurements related to the return of symptoms. For Panic Disorder, placebo-controlled research explored short-term symptom changes and reported measurements where a numerically higher proportion of observed patients receiving the active substance reported the measured outcome compared to those receiving the inactive pill.


Evidence for Specific Behavioral and Affective Conditions

Research was conducted to evaluate the active substance in other situations. For Obsessive-Compulsive Disorder (OCD), studies in both adults and youth used the Yale-Brown Obsessive Compulsive Scale (Y-BOCS). Studies reported measurements where changes in Y-BOCS scores were observed to be numerically different than those reported by the placebo.

In studies on Bulimia Nervosa, the research focused on monitoring the frequency of binge-eating episodes and purging behaviors. Measurements where differences in these behaviors were observed were reported in the group receiving the substance compared to the control group. Research on Premenstrual Dysphoric Disorder (PMDD) explored patterns related to continuous versus intermittent dosing, with changes in symptom severity scores observed across both strategies compared to the placebo.


What is Still Uncertain About Fluzac Research

Evidence quality varies across studies, and many areas still lack robust information. Long-term effects are not fully established for most indications, as follow-up durations were often limited to short or intermediate periods. Data for certain groups remain insufficient, particularly for older adults across all indications, and subgroup findings are uncertain due to modest sample sizes. Research highlights what is known—and what is still uncertain—about the substance.

Key Studies & References Short- and Long-Term Antidepressant Clinical Trials for Major Depressive Disorder in Youth: Findings and Concerns (Informs on mixed youth findings and maintenance context)

Frequently Asked Questions (FAQ)

Common questions about Fluzac (FAQ)


Q: Is Fluzac a type of antidepressant?

A: Yes. Fluoxetine, the active ingredient in Fluzac, is classified in regulatory documents as an antidepressant medication. It is approved for the treatment of specific mood, anxiety, and behavioral conditions.

Q: Why do some people call Fluzac an SSRI?

A: Fluoxetine belongs to a class of medicines known as Selective Serotonin Reuptake Inhibitors (SSRIs). This classification is based on how the drug is described to work, primarily by selectively blocking the reabsorption of the chemical messenger serotonin in the brain.

Q: What is the main purpose of taking Fluzac?

A: Official information indicates that Fluzac is used to treat specific mental health conditions including major depressive disorder, obsessive-compulsive disorder (OCD), bulimia nervosa, premenstrual dysphoric disorder, and panic disorder. These are the specific indications for which the drug has been approved.

Q: How quickly does Fluzac start to have an effect?

A: According to clinical research themes, some patients may notice initial symptom changes within the first one to two weeks of treatment. However, it may take longer, often four to eight weeks, to experience the full expected benefits as the body adapts to the medication.

Q: Is it normal to feel different in the first week of taking Fluzac?

A: Yes. Official product information notes that patients commonly experience side effects like headache, nausea, or insomnia, particularly during the initial phase of treatment. These changes are a sign that the body is adjusting to the medication.

Q: How long does the effect of Fluzac last after I stop taking it?

A: Due to the long elimination half-lives of fluoxetine and its active metabolite, the active drug substance can persist in the body for several weeks after the last dose. This extended duration means the medicine’s chemical effects may continue after treatment has ended.

Q: Can Fluzac cause weight changes?

A: Official reports on adverse reactions state that alterations in appetite and weight have been observed. While some patients may experience weight loss, particularly early in treatment, the long-term effect is generally described in studies as minimal or weight-neutral.

Q: What is the difference between Fluzac and Prozac?

A: Prozac is a widely known brand name for the generic active substance fluoxetine. Fluzac (the name used in this material) is another way to refer to the active ingredient fluoxetine. All versions contain the same active medicinal substance.

Q: If I miss a dose of Fluzac, what is generally described as the next step?

A: Patient information often describes the general approach to a missed dose: if it is remembered soon after, it may be taken. However, patients are generally cautioned against taking two doses close together or doubling a dose to make up for a missed one.

Q: Can Fluzac affect my ability to drive or use machinery?

A: Official product labeling states that fluoxetine has the potential to impair judgment, thinking, and motor skills. Patients should be aware of this potential when considering operating machinery or driving.

Q: Is Fluzac a controlled substance?

A: No. Fluoxetine, the active ingredient in Fluzac, is not classified as a controlled substance by the U.S. Drug Enforcement Administration (DEA) or similar regulatory bodies.

Q: Can Fluzac cause changes in appetite?

A: Yes. Decreased appetite has been reported in clinical trials and is listed in the official documents as a common side effect. These changes are usually minor and temporary.

Q: Is it necessary to have a medical condition to be prescribed Fluzac?

A: Yes. Fluoxetine is a prescription-only medicine approved by regulators for the treatment of specific medical conditions (indications). It cannot be obtained without an official prescription.

Q: What does the term 'contraindication' mean in relation to Fluzac?

A: A contraindication is a condition or circumstance that makes the use of a drug strictly prohibited because the risk of harm outweighs any potential benefit. For Fluzac, this includes using it with certain other medications like MAOIs due to the risk of Serotonin Syndrome.

Q: Can men and women experience different side effects from Fluzac?

A: While many side effects are common across all patients, sexual dysfunction is a reported adverse reaction. The drug is also specifically approved to treat Premenstrual Dysphoric Disorder (PMDD), which may involve sex-specific considerations in treatment.

Q: What is the risk of dependence or addiction with Fluzac?

A: Fluoxetine is not considered to be addictive and is not a controlled substance. However, abruptly stopping the medication may cause physical dependence and result in discontinuation (withdrawal) symptoms. Due to this risk, official guidance generally recommends a gradual reduction process.

Q: Can Fluzac cause strange dreams?

A: Vivid dreams or nightmares have been reported as a symptom of Antidepressant Discontinuation Syndrome, which can occur after the medication is stopped suddenly. They are not frequently listed as an ongoing side effect during active treatment.

Q: What does the term 'pharmacodynamics' mean for Fluzac?

A: The term pharmacodynamics is used in official labels to describe how the drug affects the body. For fluoxetine, the primary effect is the selective inhibition of the Serotonin Reuptake Transporter (SERT), which increases serotonin levels in the brain.

Q: What is the typical timeframe for side effects to diminish after starting Fluzac?

A: Official patient information often describes that many common side effects, such as headaches and nausea, usually improve and go away after the first week or two as the body adjusts to the medication.

Q: Does Fluzac interact with alcohol?

A: Drug interaction guidelines indicate that consuming alcohol may increase the nervous system side effects of fluoxetine, such as dizziness, drowsiness, and difficulty concentrating. Restrictions on alcohol use are generally advised.

Q: Can Fluzac cause blurred vision?

A: Yes. Official regulatory documents list abnormal vision, including blurred vision, as a possible adverse reaction.

Q: Are there any common over-the-counter medicines that interact with Fluzac?

A: Yes. Official documents require caution with medicines that affect blood clotting, such as over-the-counter NSAIDs (like ibuprofen) and aspirin. Taking these with Fluzac may increase the risk of abnormal bleeding.

Q: Is Fluzac considered a high-risk medication?

A: Regulatory labeling includes a Boxed Warning that highlights the increased risk of suicidal thoughts and behavior in children, adolescents, and young adults, particularly at the start of treatment. Serious warnings are also in place for serotonin syndrome and cardiac issues, which should be understood.

Q: Can Fluzac be used by older adults?

A: Yes. However, the official prescribing information notes that a lower or less frequent dosage schedule may be recommended for older adults due to differences in how their bodies process the medication.

Q: What happens if I stop taking Fluzac suddenly?

A: Stopping the medication suddenly may result in Antidepressant Discontinuation Syndrome, with reported symptoms that can include flu-like feelings, insomnia, nausea, or dizziness. Official guidance generally recommends a gradual reduction process.

Q: Is Fluzac approved for use in children or adolescents?

A: Yes. Fluoxetine is approved for certain conditions in younger patients, such as Major Depressive Disorder in ages 8 and older and Obsessive-Compulsive Disorder in ages 7 and older.

Q: Is there a generic version of Fluzac available?

A: Yes. Fluoxetine, the active ingredient in Fluzac/Prozac, is widely available in generic form. This is the same chemical substance as the brand name version.

Q: Can Fluzac affect my heart rate?

A: Official warnings note that fluoxetine is associated with the risk of QT interval prolongation and ventricular arrhythmias. These are serious side effects that affect the electrical activity and rhythm (rate) of the heart.

Q: Is Fluzac often prescribed long-term?

A: The medication is used for the treatment of chronic conditions like major depressive disorder and obsessive-compulsive disorder. Regulatory trials include maintenance studies that examine its use for periods up to a year or more.

Q: Why does the packaging for Fluzac mention a risk of serotonin syndrome?

A: The drug works by increasing the amount of a brain chemical called serotonin. Excessive serotonin activity, especially when combined with other serotonergic medicines, can lead to a potentially serious condition called Serotonin Syndrome.

Q: Are there certain foods or drinks that should be avoided with Fluzac?

A: Drug interaction guidelines indicate that consuming alcohol may increase nervous system side effects. Therefore, restrictions on alcohol use are generally advised. Fluoxetine may generally be taken with or without food.

Q: What conditions make someone ineligible to take Fluzac?

A: The official label lists contraindications (prohibitions) for use in patients taking Monoamine Oxidase Inhibitors (MAOIs), Pimozide, or Thioridazine due to the risk of serious adverse reactions.

Q: Is there evidence that Fluzac works better for certain age groups?

A: Official warnings note different risk profiles by age, with a reduced risk of suicidal thoughts in adults aged 65 and older and an increased risk in younger adults. However, definitive statements about effectiveness in comparison across all groups are not universally established.

How should Fluzac be stored and disposed of?

How to Store and Dispose of Fluzac (Fluoxetine)

Official regulatory documents define specific storage and disposal requirements for Fluzac (fluoxetine).


Storage Conditions

  • Temperature: Store at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F). Do not store above 25 C.
  • Protection: The medicine must be protected from light and kept in its original container and in a tight, light-resistant container.
  • Child Safety: Keep the medicine out of the sight and reach of children to prevent accidental ingestion.

Disposal Instructions

Unused or expired Fluzac must be disposed of in accordance with local regulations. Use a medicine take-back program if one is available. If not, follow specific government guidance for disposal, such as the authorized flushing protocol for certain formulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fluzac found in:

A-Z Index: